Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Human Microbiome and Prostate Cancer Development: Current Insights Into the Prevention and Treatment Publisher Pubmed



Ohadian Moghadam S1 ; Momeni SA1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Frontiers of Medicine Published:2021


Abstract

The huge communities of microorganisms that symbiotically colonize humans are recognized as significant players in health and disease. The human microbiome may influence prostate cancer development. To date, several studies have focused on the effect of prostate infections as well as the composition of the human microbiome in relation to prostate cancer risk. Current studies suggest that the microbiota of men with prostate cancer significantly differs from that of healthy men, demonstrating that certain bacteria could be associated with cancer development as well as altered responses to treatment. In healthy individuals, the microbiome plays a crucial role in the maintenance of homeostasis of body metabolism. Dysbiosis may contribute to the emergence of health problems, including malignancy through affecting systemic immune responses and creating systemic inflammation, and changing serum hormone levels. In this review, we discuss recent data about how the microbes colonizing different parts of the human body including urinary tract, gastrointestinal tract, oral cavity, and skin might affect the risk of developing prostate cancer. Furthermore, we discuss strategies to target the microbiome for risk assessment, prevention, and treatment of prostate cancer. © 2020, Higher Education Press.
Related Docs
View other Related Docs
1. Microbiome and Breast Cancer: New Role for an Ancient Population, Frontiers in Oncology (2020)
2. Role of Microbiota-Derived Short-Chain Fatty Acids in Cancer Development and Prevention, Biomedicine and Pharmacotherapy (2021)
3. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer, International Archives of Allergy and Immunology (2022)
4. The Association of Oral Microbiome Dysbiosis With Gastrointestinal Cancers and Its Diagnostic Efficacy, Journal of Gastrointestinal Cancer (2023)
5. Pd-1/Pd-L1 Blockade: Prospectives for Immunotherapy in Cancer and Autoimmunity, IUBMB Life (2021)
6. Impact of Helicobacter Pylori Infection on the Efficacy of Immune Checkpoint Inhibitors for Cancer Treatment: A Meta-Analysis, Immunotherapy (2023)
7. Bacterial Biomarkers: New Aspects of Colorectal Tumors Diagnosis: Reality or Fantasy, European Journal of Cancer Prevention (2023)
8. Diet Influences Immunotherapy Outcomes in Cancer Patients: A Literature Review, Nutrition and Cancer (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (17)
Reza Malekzadeh (5)
Other Related Docs
9. Transition Zone Prostate-Specific Antigen Density Could Better Guide the Rebiopsy Strategy in Men With Prostate Inflammation at Initial Biopsy, Urology (2015)
10. Fusobacterium Nucleatum and Colorectal Cancer: A Mechanistic Overview, Journal of Cellular Physiology (2019)
11. Fecal Profiling Reveals a Common Microbial Signature for Pancreatic Cancer in Finnish and Iranian Cohorts, Gut Pathogens (2025)
12. The Role of Inflammatory Cytokines and Tumor Associated Macrophages (Tams) in Microenvironment of Pancreatic Cancer, Cytokine and Growth Factor Reviews (2018)
13. Resistance Mechanisms to Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Inhibitors, Expert Opinion on Biological Therapy (2021)
14. Probiotics for Prophylaxis and Management of Breast Cancer: Preclinical and Clinical Evidence, Probiotic Research in Therapeutics: Volume 1: Applications in Cancers and Immunological Diseases (2020)
15. Molecular Mechanisms of Curcumins Suppressing Effects on Tumorigenesis, Angiogenesis and Metastasis, Focusing on Nf-Κb Pathway, Cytokine and Growth Factor Reviews (2016)
16. The Critical Role of Faecalibacterium Prausnitzii in Human Health: An Overview, Microbial Pathogenesis (2020)
17. Diabetes Management by Probiotics: Current Knowledge and Future Perspectives, International Journal for Vitamin and Nutrition Research (2016)
18. The Interplay Between Human Papillomavirus and Vaginal Microbiota in Cervical Cancer Development, Virology Journal (2023)
19. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
20. The Future of Diabetes Management by Healthy Probiotic Microorganisms, Current Diabetes Reviews (2017)
21. Immune Checkpoint Inhibitor (Ici) Therapy in Central Nervous System Cancers: State-Of-The-Art and Future Outlook, International Immunopharmacology (2025)
22. The Impact of Succinate Dehydrogenase Gene (Sdh) Mutations in Renal Cell Carcinoma (Rcc): A Systematic Review, OncoTargets and Therapy (2019)
23. Oral Microbial Community Composition Is Associated With Pancreatic Cancer: A Case-Control Study in Iran, Cancer Medicine (2020)
24. Gut Microbiota As a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents, Hormone and Metabolic Research (2016)
25. The Microbiome in Precision Medicine: A New Approach to Cancer Treatment, Journal of Mazandaran University of Medical Sciences (2021)
26. Immunomodulatory Effects of Lactobacillus Strains: Emphasis on Their Effects on Cancer Cells, Immunotherapy (2015)
27. Immune Checkpoint Inhibitors: Review of the Existing Evidence and Challenges in Breast Cancer, Immunotherapy (2021)
28. Epstein-Barr and Bk Virus in Cancerous and Noncancerous Prostate Tissue, Future Virology (2020)
29. Review of the Recent Clinical Trials for Pd-1/Pd-L1 Based Lung Cancer Immunotherapy, Expert Review of Anticancer Therapy (2021)
30. Ctla-4: As an Immunosuppressive Immune Checkpoint in Breast Cancer, Current Molecular Medicine (2023)
31. Oral Microbiota in Cancer: Could the Bad Guy Turn Good With Application of Polyphenols?, Expert Reviews in Molecular Medicine (2023)
32. Probiotics With Ameliorating Effects on the Severity of Skin Inflammation in Psoriasis: Evidence From Experimental and Clinical Studies, Journal of Cellular Physiology (2020)
33. Quantitative Analysis of the Three Gut Microbiota in Uc and Non-Uc Patients Using Real-Time Pcr, Microbial Pathogenesis (2023)
34. Microbes: Possible Link Between Modern Lifestyle Transition and the Rise of Metabolic Syndrome, Obesity Reviews (2019)
35. Current and Future Perspectives of Pd-1/Pdl-1 Blockade in Cancer Immunotherapy, Journal of Immunology Research (2021)
36. Exhaustion of T Lymphocytes in the Tumor Microenvironment: Significance and Effective Mechanisms, Cellular Immunology (2017)
37. Role of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Predicting the Response to First Line Chemotherapy in Colorectal Cancer Patients With Synchronous Liver Metastases: A Retrospective Study, International Journal of Cancer Management (2021)
38. Mirnas in Outer Membrane Vesicles of Gut Microbiota: Friend or Foe?, Microbial Pathogenesis (2020)
39. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders, International Journal of Molecular Sciences (2019)
40. Microbiota and Probiotics, a New Approach in the Prevention and Treatment of Breast Cancer: A Review Article; [میکروبیوتا و پروبیوتیکها، رویکردی نوین در پیشگیری و درمان سرطان پستان: یک مقاله مروری], Tehran University Medical Journal (2024)
41. Incidence, Mortality, and Epidemiological Aspects of Cancers in Iran; Differences With the World Data, Journal of B.U.ON. (2016)
42. Inhibitors of the Pi3k/Akt/Mtor Pathway in Prostate Cancer Chemoprevention and Intervention, Pharmaceutics (2021)
43. Exploring the Effect of Gut Microbiome on Alzheimer's Disease, Biochemistry and Biophysics Reports (2024)
44. Modulation of Efferocytosis and Inflammation Resolution by Live and Non-Live Probiotics Through Gut Microbiota Interactions in Preclinical and Clinical Studies, Food Bioscience (2024)
45. Lifestyle Alters Gut-Bacteria Function: Linking Immune Response and Host, Best Practice and Research: Clinical Gastroenterology (2017)
46. Association Between Some Helminths and Tumorigenesis Through Immunological and Biochemical Factors, Current Cancer Therapy Reviews (2023)
47. Composition of the Gut Microbiome, Role of Diet, Lifestyle, and Antioxidant Therapies in Diabetes Mellitus and Diabetic Retinopathy, European Journal of Ophthalmology (2024)
48. Tumor-Associated Macrophages: Role in Cancer Development and Therapeutic Implications, Cellular Oncology (2019)
49. Solid Tumors Challenges and New Insights of Car T Cell Engineering, Stem Cell Reviews and Reports (2019)
50. Anti-Tumor Activities of Probiotics in Cervical Cancer, Journal of Ovarian Research (2020)